Portman Square Capital’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-170,400
Closed -$5.17M 120
2025
Q3
$5.17M Sell
170,400
-202,100
-54% -$6.13M 0.23% 61
2025
Q2
$11.7M Buy
372,500
+82,300
+28% +$2.72M 0.34% 66
2025
Q1
$11.1M Sell
290,200
-114,500
-28% -$4.86M 0.29% 94
2024
Q4
$17.8M Hold
404,700
0.64% 34
2024
Q3
$17.4M Buy
404,700
+164,500
+68% +$7.33M 0.65% 40
2024
Q2
$10.9M Sell
240,200
-135,500
-36% -$7.03M 0.37% 87
2024
Q1
$23.5M Hold
375,700
0.65% 44
2023
Q4
$21M Buy
+375,700
New +$18.7M 0.48% 55

Other funds holding ENOV

Portman Square Capital's ENOV Position: Q3 2024 in Review

Portman Square Capital sold out of Enovis (ENOV) in Q3 2024, closing a stake of 10,683 shares — an estimated $476K sold.

Portman Square Capital first reported a position in ENOV in Q2 2024 and held it in 1 quarter. The position peaked at $483K in Q2 2024. 283 funds tracked by Wall St. Rank hold ENOV as of Q3 2024.

  • Portman Square Capital reported no remaining Enovis position as of Q3 2024 after selling out during the quarter.
  • Portman Square Capital sold 10,683 Enovis shares in Q3 2024, an estimated $476K.
  • Portman Square Capital first reported a position in Enovis in Q2 2024 and held it in 1 quarter.
  • Portman Square Capital's Enovis position peaked at $483K in Q2 2024.
  • 283 funds tracked by Wall St. Rank held Enovis as of Q3 2024.

Based on Portman Square Capital's 13F filing for Q3 2024, filed 16 Oct 2024.